- Published on
Medicine - B Lymphocytes (B Cells)
B lymphocytes (B cells) are lymphocytes primarily responsible for humoral immunity, involving antibody production against pathogens, toxins and other antigens.
B cells develop in the bone marrow. Following antigen-specific activation, they undergo clonal expansion and differentiate into antibody-secreting plasma cells and memory B cells.
B cells also function as antigen-presenting cells and produce cytokines that regulate immune responses.
- B cells develop in the bone marrow.
- Approximately 5-20% of circulating lymphocytes.
- Express highly specific B-cell receptors (BCRs).
- Undergo clonal expansion after activation.
- Differentiate into plasma cells and memory B cells.
- Produce antibodies through plasma-cell differentiation.
- Present antigens to CD4+ T cells through MHC II.
- Produce cytokines that regulate immunity.
1. Origin and Maturation of B Lymphocytes
A. Origin
B lymphocytes originate from lymphoid progenitor cells derived from haematopoietic stem cells in the bone marrow.
During development, B cells rearrange immunoglobulin genes to generate antigen-specific receptors.
B. B-Cell Development
C. Central Tolerance
Immature B cells that strongly recognise self-antigens may undergo:
- Receptor editing.
- Clonal deletion.
- Anergy (functional inactivation).
Transitional B cells subsequently complete maturation in peripheral lymphoid tissues, particularly the spleen.
2. Proportion of B Lymphocytes
B cells typically account for approximately 5-20% of circulating lymphocytes in healthy adults.
The proportion varies with age, laboratory methods and clinical circumstances.
| Lymphocyte Type | Approximate Proportion |
|---|---|
| T lymphocytes | 60-80% |
| B lymphocytes | 5-20% |
| Natural killer cells | 5-20% |
Important Surface Markers
- CD19: Common B-cell lineage marker.
- CD20: Expressed on many mature B cells; generally absent from plasma cells.
- CD21: Complement receptor 2; also binds Epstein-Barr virus.
- CD40: Important for interactions with helper T cells.
- Surface IgM and IgD: Antigen receptors on most mature naive B cells.
3. Surface Immunoglobulin and Antigen Recognition
B lymphocytes express highly specific membrane-bound immunoglobulins that function as B-cell receptors (BCRs).
A. B-Cell Receptor
The BCR consists of:
- Membrane-bound immunoglobulin.
- Ig-alpha (CD79a).
- Ig-beta (CD79b).
CD79a and CD79b transmit activation signals into the B cell following antigen binding.
B. Antigen Specificity
Each conventional B-cell clone expresses receptors with a particular antigen-binding specificity.
This diversity is generated by V(D)J recombination of immunoglobulin genes during B-cell development.
C. Antigen Recognition
Unlike conventional T cells, B cells can directly recognise native antigens, including:
- Proteins.
- Polysaccharides.
- Lipids.
- Other molecular structures.
4. Activation of B Lymphocytes
B cells become activated when their specific antigen binds to the BCR and appropriate additional activation signals are received.
A. T-Dependent B-Cell Activation
T-dependent activation is particularly important for protein antigens.
- The BCR recognises a protein antigen.
- The antigen is internalised and processed.
- Peptide fragments are presented on MHC class II.
- A cognate CD4+ helper T cell, particularly a T follicular helper (Tfh) cell, recognises the peptide-MHC II complex.
- CD40 on the B cell interacts with CD40L on the helper T cell.
- Cytokines, including IL-21, support B-cell activation.
- The B cell proliferates and differentiates.
Visual Flowchart: B-Cell Activation
T-dependent activation can produce:
- Class-switch recombination.
- Somatic hypermutation.
- Affinity maturation.
- Memory B cells.
- Long-lived plasma cells.
B. T-Independent B-Cell Activation
Some antigens activate B cells without conventional cognate T-cell help, especially antigens with repetitive structures such as bacterial capsular polysaccharides.
- Often predominantly IgM production.
- Generally less germinal-centre activity.
- More limited affinity maturation.
- Often weaker immunological memory.
Some T-independent responses can nevertheless produce class-switched antibodies and memory-like B-cell populations.
5. Clonal Expansion and Differentiation
Following activation, antigen-specific B cells undergo clonal expansion, producing many descendant cells with related antigen specificity.
A. Plasma Cells
Plasma cells are specialised for antibody secretion.
Characteristics:- Abundant rough endoplasmic reticulum.
- Prominent Golgi apparatus.
- Eccentrically located nucleus.
- Clock-face or cartwheel chromatin.
- High-rate antibody secretion.
Long-lived plasma cells may persist in bone marrow survival niches.
B. Memory B Cells
Memory B cells persist after an immune response and enable a faster response when the antigen is encountered again.
- Can persist for long periods.
- Respond rapidly to repeat antigen exposure.
- Often possess increased antigen affinity after germinal-centre maturation.
- Contribute to vaccine-induced immunity.
Plasma Cells Versus Memory B Cells
| Feature | Plasma Cells | Memory B Cells |
|---|---|---|
| Main role | Antibody secretion | Immune memory |
| Antibody secretion | High | Usually low or absent until reactivation |
| Lifespan | Short- or long-lived | Often long-lived |
| CD20 | Usually absent | Generally present |
6. Functions of B Lymphocytes
A. Antibody Production
Antibody production is the principal function of the B-cell lineage. Activated B cells can differentiate into plasma cells that secrete immunoglobulins.
| Immunoglobulin | Main Function |
|---|---|
| IgM | Early antibody responses; classical complement activation |
| IgG | Neutralisation, opsonisation, complement and fetal immunity |
| IgA | Mucosal immunity |
| IgE | Type I hypersensitivity and helminth defence |
| IgD | Primarily a B-cell antigen receptor |
Antibodies contribute to:
- Neutralisation.
- Opsonisation.
- Complement activation.
- Agglutination.
- Antibody-dependent cellular cytotoxicity (ADCC).
B. Antigen Presentation
B cells are professional antigen-presenting cells capable of presenting processed peptide antigens to CD4+ helper T cells through MHC class II molecules.
Visual Flowchart: Antigen Presentation
B cells are especially effective at presenting antigens recognised by their own BCR. Dendritic cells, however, are generally more important for initial priming of naive T cells.
C. Cytokine Production
B cells can produce cytokines that regulate immune responses.
- IL-6: Supports inflammatory and lymphocyte responses.
- IL-10: Important in immunoregulatory B-cell functions.
- TNF: Contributes to inflammatory signalling.
- Lymphotoxin: Contributes to lymphoid tissue organisation.
Regulatory B-cell populations (Bregs) can suppress excessive immune responses, partly through IL-10 production.
7. Germinal-Centre Reaction
Germinal centres develop in secondary lymphoid organs during many T-dependent antibody responses.
Major Processes
- Clonal proliferation: Activated B cells proliferate.
- Somatic hypermutation: Mutations occur in immunoglobulin variable-region genes.
- Affinity maturation: Higher-affinity B-cell clones are preferentially selected.
- Class-switch recombination: Immunoglobulin heavy-chain constant regions change while antigen specificity is generally retained.
Somatic hypermutation and class-switch recombination require activation-induced cytidine deaminase (AID).
Visual Flowchart: Germinal-Centre Response
8. Primary and Secondary Immune Responses
Primary Immune Response
- Naive B cells are activated after first antigen exposure.
- IgM is usually produced early.
- Class switching may subsequently occur.
- Plasma cells and memory B cells develop.
Secondary Immune Response
- Memory B cells respond rapidly.
- Antibody production is often greater.
- Class-switched antibodies, particularly IgG in many systemic responses, may predominate.
- Antibodies are often of higher affinity.
These features contribute to vaccine-induced immunity and long-term immunological memory.
9. Clinical Associations
A. X-Linked Agammaglobulinaemia
X-linked agammaglobulinaemia (Bruton disease) is commonly caused by mutations in the BTK gene, impairing B-cell maturation.
- Markedly reduced mature B cells.
- Very low immunoglobulin concentrations.
- Recurrent bacterial infections.
- Small or absent tonsils and lymphoid follicles.
- Often presents after maternal IgG declines.
B. Common Variable Immunodeficiency (CVID)
CVID is a heterogeneous antibody deficiency disorder characterised by reduced IgG and impaired antibody responses, often with reduced IgA and/or IgM.
- Recurrent sinopulmonary infections.
- Bronchiectasis.
- Autoimmune disease.
- Gastrointestinal disease.
- Increased risk of certain lymphoproliferative disorders.
C. Hyper-IgM Syndromes
Hyper-IgM syndromes involve impaired immunoglobulin class switching.
Possible defects include:
- CD40L.
- CD40.
- AID.
- Other proteins involved in class-switch recombination.
D. B-Cell Malignancies
- Chronic lymphocytic leukaemia.
- Diffuse large B-cell lymphoma.
- Follicular lymphoma.
- Burkitt lymphoma.
- Multiple myeloma (plasma-cell malignancy).
E. B-Cell-Targeted Therapy
Rituximab is a monoclonal antibody directed against CD20 and is used in selected B-cell malignancies and autoimmune diseases.
Because most mature plasma cells lack CD20, rituximab does not directly eliminate most established long-lived plasma cells.
10. B Cells Versus T Cells
| Feature | B Cells | T Cells |
|---|---|---|
| Origin | Bone marrow | Bone marrow |
| Maturation | Bone marrow and peripheral tissues | Thymus |
| Immunity | Humoral | Cell-mediated and regulatory |
| Receptor | BCR | TCR |
| Antigen recognition | Native antigens | Usually peptide-MHC |
| Markers | CD19, CD20 | CD3, CD4, CD8 |
| Effector function | Antibody production | Cytokines or cytotoxicity |
11. Important Corrections
- B-cell development occurs in bone marrow, with final transitional maturation in peripheral lymphoid tissues.
- B cells typically form approximately 5-20% of circulating lymphocytes, not a fixed 30%.
- Each B-cell clone expresses a highly specific BCR.
- The BCR includes membrane immunoglobulin and CD79a/CD79b.
- Antigen-specific activation causes clonal expansion.
- Activated B cells can differentiate into plasma cells and memory B cells.
- Plasma cells are specialised for high-rate antibody secretion.
- B cells present processed peptide antigens to CD4+ T cells through MHC II.
- B-cell cytokines can stimulate or suppress immune responses.
- B cells participate in class switching, affinity maturation and immunological memory.
12. High-Yield Examination Summary
- Bone marrow origin and development.
- Final transitional maturation in peripheral lymphoid tissues.
- Approximately 5-20% of circulating lymphocytes.
- BCR with membrane-bound immunoglobulin.
- CD19, CD20, CD21 and CD40.
- Surface IgM and IgD on mature naive B cells.
- Specific antigen recognition.
- Clonal expansion.
- T-dependent activation through CD40-CD40L.
- Plasma cells: Antibody secretion.
- Memory B cells: Rapid secondary immune responses.
- Antibody production.
- Antigen presentation through MHC II.
- Cytokine production and immune regulation.
- X-linked agammaglobulinaemia.
- CVID.
- Hyper-IgM syndromes.
- B-cell malignancies.
B lymphocytes develop in the bone marrow and mediate humoral immunity.
Following antigen-specific activation, they undergo clonal expansion and differentiate into plasma cells that secrete antibodies and memory B cells that provide long-term immunological memory.
Medicine - Immunology Revision Notes